ICVTS Click here to goto Smart Canula website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2009;8:381. doi:10.1510/icvts.2008.195909A
© 2009 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Murat Basaran
Nuri Kurtoglu
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ugurlucan, M.
Right arrow Articles by Us, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ugurlucan, M.
Right arrow Articles by Us, M. H.
Related Collections
Right arrowRelated Article

eComment

eComment: Complications of late thrombolytic therapy in the elderly

Murat Ugurlucan, Murat Basaran, Nuri Kurtoglu and Melih H. Us

Goztepe Safak Hospital Cardiovascular Surgery Clinic, Istanbul, Turkey

Post-infarct ventricular septal defect following thrombolytic intracranial bleed

We read with great interest the article by Firstenberg et al. [1] presenting a case of post-myocardial infarction (MI) ventricular septal defect (VSD) and intracranial hemorrhage following thrombolytic therapy after acute stent occlusion. We would like to comment the authors' aritcle with our modest experience of similar complications.

Myocardial or aortic rupture, aortic dissection, intracranial hemorrhage, or even splenic rupture are potential fatal complications of thrombolytic therapy following acute myocardial infarction. They usually occur in elderly (>65 years of age), moderate body weight (<70 kg) female subjects. Hypertension at presentation and usage of tissue plasminogen activator (t-PA) rather than streptokinase have shown to be additional risk factors. Of the most important, timing of the lytic therapy is accepted as the critical factor for post-MI VSD and intracranial bleeding. Initiation of the therapy beyond 12 h following the onset of MI is a major risk. Although the mechanism behind such complications following thrombolytic agents is not clear, it is suggested that recanalization with medical thrombolysis may lead to microvascular hemorrhage, interstitial edema and contraction band necrosis as well as to a decrease in fibrinogen and elongated partial thromboplastin times especially with the usage of t-PA [2–4].

At our institution, we have been faced with one post-MI VSD and another intracranial bleeding in two female patients aged 74 and 78 years who underwent thrombolytic therapy at 12 and 18 h of the onset of symptoms for the left anterior descending coronary artery occlusion related acute MI. Both patients were managed accordingly and successfully (unpublished data). Since then we prefer to use mechanical recanalization in every particular case when it is possible. Medical revascularization is seldomly favoured and is done mostly in younger age group male patients.

In order to better study the risks of such complications, it would be more appropriate if the authors could give detailed information about the blood pressure of the patient on admission and at the time of the intervention. Additionally, what was the time interval between the diagnosis and the initiation of the thrombolytic therapy?

We would like to congratulate the authors for their successful management [1] in such a challenging case.


    References
 Top
 References
 

  1. Firstenberg MS, Blais D, Rea G, Bush CA. Post-infarct ventricular septal defect following thrombolytic intracranial bleed. Interact CardioVasc Thorac Surg 2009;8:379–381.[Abstract/Free Full Text]
  2. Kaplan KL, Fitzpatrick P, Cox C, Shammas NW, Marder VJ. Use of thrombolytic therapy for acute myocardial infarction: effects of gender and age on treatment rates. J Thromb Thrombolysis 2002;13:21–26.[CrossRef][Medline]
  3. Lincoff AM, Califf RM, Ellis SG, Sigmon KN, Lee KL, Leimberger JD, Topol EJ. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1993;22:1780–1787.[Abstract]
  4. Mallik S, Vaccarino V. Outcomes of thrombolytic therapy for acute myocardial infarction in women. Prog Cardiovasc Dis 2004;47:58–71.[CrossRef][Medline]

Related Article

Post-infarct ventricular septal defect following thrombolytic intracranial bleed
Michael S. Firstenberg, Danielle Blais, Gary Rea, and Charles A. Bush
Interactive CardioVascular and Thoracic Surgery 2009 8: 379-381. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Murat Basaran
Nuri Kurtoglu
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ugurlucan, M.
Right arrow Articles by Us, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ugurlucan, M.
Right arrow Articles by Us, M. H.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS